Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Sarah K. Lyons; Julia M. Hermann; Kellee M. Miller; Sabine E. Hofer; Nicole C. Foster; Birgit M. Rami-Merhar; Grazia Aleppo; Jochen Seufert; Linda A. DiMeglio; Thomas Danne; David M. Maahs; Reinhard W. Holl

doi:10.2337/dc17-0403

Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Sarah K. Lyons, Julia M. Hermann, Kellee M. Miller^*, Sabine E. Hofer, Nicole C. Foster, Birgit M. Rami-Merhar, Grazia Aleppo, Jochen Seufert, Linda A. DiMeglio, Thomas Danne, David M. Maahs, Reinhard W. Holl

^*Corresponding author for this work

Medicine, Endocrinology Division

Research output: Contribution to journal › Letter › peer-review

45 Scopus citations

Original language	English (US)
Pages (from-to)	e139-e140
Journal	Diabetes care
Volume	40
Issue number	10
DOIs	https://doi.org/10.2337/dc17-0403
State	Published - Oct 1 2017

Funding

Funding. The T1D Exchange is supported through the Leona M. and Harry B. Helmsley Charitable Trust. The DPV is supported through the German Federal Ministry of Education and Research (BMBF) Competence Network Diabetes Mellitus (FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) as of January 2015. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. S.K.L. contributed to data interpretation and wrote and edited the manuscript. J.M.H. performed statistical analysis and contributed to data interpretation. K.M.M., S.E.H., N.C.F., B.M.R.-M., G.A., J.S., L.A.D., T.D., D.M.M., and R.W.H. contributed to data interpretation and reviewed and edited the manuscript. R.W.H. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc17-0403

Cite this

Lyons, S. K., Hermann, J. M., Miller, K. M., Hofer, S. E., Foster, N. C., Rami-Merhar, B. M., Aleppo, G., Seufert, J., DiMeglio, L. A., Danne, T., Maahs, D. M., & Holl, R. W. (2017). Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries. Diabetes care, 40(10), e139-e140. https://doi.org/10.2337/dc17-0403

@article{808706e1ea7845f7bb2337541b735be7,

title = "Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries",

author = "Lyons, {Sarah K.} and Hermann, {Julia M.} and Miller, {Kellee M.} and Hofer, {Sabine E.} and Foster, {Nicole C.} and Rami-Merhar, {Birgit M.} and Grazia Aleppo and Jochen Seufert and DiMeglio, {Linda A.} and Thomas Danne and Maahs, {David M.} and Holl, {Reinhard W.}",

note = "Funding Information: Funding. The T1D Exchange is supported through the Leona M. and Harry B. Helmsley Charitable Trust. The DPV is supported through the German Federal Ministry of Education and Research (BMBF) Competence Network Diabetes Mellitus (FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) as of January 2015. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. S.K.L. contributed to data interpretation and wrote and edited the manuscript. J.M.H. performed statistical analysis and contributed to data interpretation. K.M.M., S.E.H., N.C.F., B.M.R.-M., G.A., J.S., L.A.D., T.D., D.M.M., and R.W.H. contributed to data interpretation and reviewed and edited the manuscript. R.W.H. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.",

year = "2017",

month = oct,

day = "1",

doi = "10.2337/dc17-0403",

language = "English (US)",

volume = "40",

pages = "e139--e140",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "10",

}

Lyons, SK, Hermann, JM, Miller, KM, Hofer, SE, Foster, NC, Rami-Merhar, BM, Aleppo, G, Seufert, J, DiMeglio, LA, Danne, T, Maahs, DM & Holl, RW 2017, 'Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries', Diabetes care, vol. 40, no. 10, pp. e139-e140. https://doi.org/10.2337/dc17-0403

TY - JOUR

T1 - Use of adjuvant pharmacotherapy in type 1 diabetes

T2 - International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

AU - Lyons, Sarah K.

AU - Hermann, Julia M.

AU - Miller, Kellee M.

AU - Hofer, Sabine E.

AU - Foster, Nicole C.

AU - Rami-Merhar, Birgit M.

AU - Aleppo, Grazia

AU - Seufert, Jochen

AU - DiMeglio, Linda A.

AU - Danne, Thomas

AU - Maahs, David M.

AU - Holl, Reinhard W.

N1 - Funding Information: Funding. The T1D Exchange is supported through the Leona M. and Harry B. Helmsley Charitable Trust. The DPV is supported through the German Federal Ministry of Education and Research (BMBF) Competence Network Diabetes Mellitus (FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) as of January 2015. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. S.K.L. contributed to data interpretation and wrote and edited the manuscript. J.M.H. performed statistical analysis and contributed to data interpretation. K.M.M., S.E.H., N.C.F., B.M.R.-M., G.A., J.S., L.A.D., T.D., D.M.M., and R.W.H. contributed to data interpretation and reviewed and edited the manuscript. R.W.H. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85033228734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033228734&partnerID=8YFLogxK

U2 - 10.2337/dc17-0403

DO - 10.2337/dc17-0403

M3 - Letter

C2 - 28768688

AN - SCOPUS:85033228734

SN - 0149-5992

VL - 40

SP - e139-e140

JO - Diabetes care

JF - Diabetes care

IS - 10

ER -

Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this